Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
about
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunological and clinical con ...... ient treated with natalizumab.
@en
Immunological and clinical con ...... ient treated with natalizumab.
@nl
type
label
Immunological and clinical con ...... ient treated with natalizumab.
@en
Immunological and clinical con ...... ient treated with natalizumab.
@nl
prefLabel
Immunological and clinical con ...... ient treated with natalizumab.
@en
Immunological and clinical con ...... ient treated with natalizumab.
@nl
P2093
P2860
P356
P1476
Immunological and clinical con ...... ient treated with natalizumab.
@en
P2093
Alexandra B Lämmer
Anne Waschbisch
Arnd Doerfler
De-Hyung Lee
Ralf A Linker
Stefan Schwab
P2860
P2888
P356
10.1186/1742-2094-10-123
P577
2013-10-09T00:00:00Z
P5875
P6179
1003104144